All mice were fed a regular diet with drinking water ad libitum and under controlled SPF conditions (22°C, 55% humidity, and 12-hour day-night rhythm). Seventy percent partial hepatectomy (PHx) or sham surgery was performed on either 3-month-old or 6-month-old Mdr2-KO mice as described (1, 2).
Technologies). The corresponding Cy3-and Cy5-labeled DNA were combined and hybridized at 65°C 24 hours to an Agilent Mouse Genome CGH Microarray 4x44K, using Agilent's recommended hybridization chamber and oven. Subsequently, the microarrays were washed once with Agilent Oligo aCGH Wash Buffer 1 at room temperature for 5 minutes followed by a second wash with Agilent Oligo aCGH Wash Buffer 2 at 37 °C for one minute. Finally, the microarray was washed once with acetonitril for one minute at room temperature and slowly removed from the acetonitril solution to let it dry at room temperature. (ii) Minimum absolute average log2 ratio for region = 0.4 corresponds to a fold change of 1.32.
(iii) The statistical analysis of aberrant regions was based on the aberration detection method ADM-2.
RNA purification and cDNA synthesis
Total RNA was isolated from frozen liver tissues with Trizol reagent (Invitrogen, Carlabad, CA, USA) followed by twice Phenol-Chlorophorm extraction and isopropanol precipitation. The cDNA was obtained from 1 µg total liver RNA. Twelve units of the RNasine RNase inhibitor and 1/25ul random hexamer primers (Promega, WI, USA) in DEPC-treated water were preheated at 90 o C for 1 min to denature secondary structures. The mixture was then cooled gradually (0. 
Semi-quantitative PCR
Dream-Taq Polymerase mix (ThermoFisher-Scientific, Massachusetts, USA), was used for semi-qPCR.
For each gene, the cDNA concentration and the number of PCR cycles were established in the linear amplification range. Primers were used at a concentration of 0.5 µM. PCR was performed using the DreamTaq PCR Master Mix (Life Technologies, CA, USA) on a KyraTec PCR machine (KyraTec, Australia). The PCR products were separated on 2% agarose gels in TAE buffer, stained with ethidium bromide (0.01% v/v), and photographed by the B.I.S. 202D BioImaging System (Amersham Pharmacia Biotech, USA). Intensities of the bands were quantified using the ImageJ 1.47t Image software (NIH, USA). After normalization versus the endogenous "housekeeping" genes, Crk, Tfg, Arl6ip1 and Hprt, which were the most uniformly expressed genes in all RNA samples, were subjected to global gene expression profiling (3).
Gene-specific primers were selected using the Primer blast software (NCBI, USA), and verified using Histological sections were reviewed and characterized by the pathologist (O.P.) for inflammation, mitotic incidence, tissue damage, and cell homogeneity. Liver tumors were characterized, and only those assigned as "well differentiated HCCs" were used for further experiments.
Bradford protein quantification assay
The protein content of each lysate sample was quantified by the Bradford assay. A standard curve of OD against increasing protein concentration was established for each protein sample using serial dilutions of BSA standard protein (1 mg/ml) and a Coomassie blue based dye reagent (Bio-RAD). 1 / 2.5 / 5 / 10 / 20 / 40 μl of standard lysate samples were incubated with 200 μl of Coomassie reagent (diluted 1:5 with DDW) and OD at 595nm was immediately measured by spectrophotometer.
Protein immunoblotting
Lysates were obtained from the whole liver; tissues were prepared by manual homogenization of liver tissue in liquid nitrogen and 400 μl protein lysis buffer containing 50 mM Tris pH 7.6, 150 mM NaCl, 20 mM MgCl2, 1% NP40, 1 mM DTT, 5% glycerol, 1 mM PMSF and 2.5 μl/ml of protease inhibitor 
Immunohistopathology staining.
Liver tissue paraffin-embedded sections were mounted on glass slides, deparaffinized and graduated with ethyl alcohol, as follows: Xylyne×2, ethanol-100%×2, ethanol-95%×1, ethanol-80%×1, ethanol-60%×1
ethanol-30%×1 and TBS×1 (5 min every step). Antigen retrieval was done with 0.01 M citrate buffer (pH 6.0) in a microwave (100% power for 13 min followed by 60% for 20 min) using a pressure cooker. The slides were washed 3 times with PBS or TBS and then labeled with a secondary HRP-conjugated streptavidin antibody. After washes (3 times, 10 min), color development with diaminobenzidine was done using the Zymed kit followed by Haematoxylin counterstaining immersed with Haematoxylin (1 min), rinsed in tap water and left for an additional 2 min to develop the stain . Rehydration and clearing were done inversely for deparaffinization and dehydration. The slides were covered in a similar manner as with the histopatology staining method. Below are listed the antibodies used in this study either for 
Assessment of proliferative response, DNA damage and apoptosis
To assess the proliferative response of hepatocytes, mice were injected intraperitoneally (i.p.) with BrdU (100 gr/1 gr of mouse weight; MP Biomedicals, France), at 2 hrs before sacrifice. Formalin-fixed livers were embedded in paraffin. Antigen retrieval of FFPE liver sections was performed in citrate buffer (pH 6.0) for 20 min in a microwave; then sections were stained with the monoclonal anti-BrdU antibody (1/100) (Dako Cytomation, Tel Aviv, Israel), using a standard direct HRP method according to the manufacturer's instructions. Similarly to the pH3 protocol (1/1000), Diaminobenzidine (DAB)
Histochemistry Kits (Life Technologies) was used for color development and sections were counterstained with haematoxylin (Polysciences, Inc., 400 Valley Road Warrington, PA 18976).
Mitotic events were counted in slides stained for hematoxylin only. Assessment of a proliferative response was performed by counting positively stained hepatocytes cells within at least 20 fields per slide, magnification x200.
To assess the DNA damage in hepatocytes, FFPE slides were stained for γH2Ax (1/1000), and for the DNA damage arrest protein P21 (1/25).
To assess the apoptosis, TUNEL staining was performed using the in situ Cell Death Detection Kit (Life Technologies) as described by the manufacturer.
Cell cultures
The human HCC cell lines Huh7, Hep3b, HepaRG, and HepG2 and the murine cell lines Bnl, Bwtg, and 
Cell proliferation assay
Cell proliferation rate was measured by proliferation assay using a xCELLigence system for real-time and label-free monitoring of cell viability (4), in duplicates. Hep40 and Huh7 cell lines were treated with 25 nM/ul of Crem siRNA, and mock or siLuc as controls. The siRNA reagent kits were purchased from Santa Cruz (sc-37700). siRNAs were transfected using the LipofectAMINE 2000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions after cells were grown to 50%
confluence. Briefly, 1 μL LipofectAMINE was diluted in 50 μL OptiMEMI Reduced Serum Medium (Invitrogen, Carlsbad, CA, USA), mixed gently, and incubated for 5 min at room temperature.
Subsequently, a mixture of siRNA was added and incubated for 20 min. The mixture was diluted with medium and the final concentration of siRNA was 25 nM. After treatment for the indicated time period, cells were collected for further investigation. Alternatively, cells were measured for proliferation using the xCELLigence system.
Statistical analysis and calculation software.
In this study, the in vitro experiments were performed in triplicates, excluding the cell proliferation rate assay using a xCELLigence system, which was performed in duplicates; in the in vivo experiments, at least 3 mice per group were used. All parameters were evaluated with the two-tailed t-test. Statistical evaluation of differential expression between the experimental groups was performed using the ANOVA HCC starting from the age of 12 months. Untreated Mdr2-KO/FVB mice were terminated at the age of 13 months (females) or 14 months (males). 70% PHx was performed on Mdr2-KO/FVB mice of both sexes, at the age of either three or six months; then, all hepatectomized mice were terminated at the age of nine months.
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